SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cell Genesys (CEGE)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: tuck who wrote (1271)2/25/2004 4:07:55 PM
From: tuck  Read Replies (1) of 1298
 
>>12:23PM CEGE follow-up 13.96 -0.83: As mentioned at 12:18, co stated during its conference call that the Phase II GVAX study for lung cancer has not been halted. Co is unable to provide data from the current trial, but believes these results will be available for public review sometime in Q4. (See 11:18 and 11:28 comments for more on the rumor that hit the stock.) Conference call is still ongoing...<<

The stock has not entirely recovered. Buying op?

Cheers, Tuck
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News